Pancreatic cancer/X
Nov 24, 2024, 15:35
A newer class of drugs that target pancreatic cancer may get a helping hand from an old treatment workhorse
NCI Center for Cancer Research shared on LinkedIn:
” Christine Alewine, from our Laboratory of Molecular Biology, was interviewed for this article! Read more below about pancreatic cancer treatments using chemotherapy.
A newer class of drugs that target pancreatic cancer may get a helping hand from an old treatment workhorse: chemotherapy. Two new studies in mice show that adding chemotherapy to an experimental KRAS inhibitor called MRTX1133 greatly reduced tumor growth and spread compared with either treatment alone. ”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 24, 2024, 15:31
Nov 24, 2024, 15:25
Nov 24, 2024, 15:12
Nov 24, 2024, 14:19
Nov 24, 2024, 14:09
Nov 24, 2024, 14:05